These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 35544376)

  • 21. Liver Transplantation for Non-hepatocellular Carcinoma Malignancy: A Single-Center Experience.
    Mont Alverne Pierre AM; Veras CM; Esmeraldo TM; Schwermann MP; Studart E Neves MS; Bastos Pinho JE; Canito Brasil IR
    Transplant Proc; 2019 Dec; 51(10):3355-3359. PubMed ID: 31669072
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proposal of a novel MELD exception point system for hepatocellular carcinoma based on tumor characteristics and dynamics.
    Bhat M; Ghali P; Dupont B; Hilzenrat R; Tazari M; Roy A; Chaudhury P; Alvarez F; Carrier M; Bilodeau M
    J Hepatol; 2017 Feb; 66(2):374-381. PubMed ID: 27751840
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combined hepatocellular carcinoma and intrahepatic cholangiocarcinoma: outcome after liver transplantation.
    Maganty K; Levi D; Moon J; Bejarano PA; Arosemena L; Tzakis A; Martin P
    Dig Dis Sci; 2010 Dec; 55(12):3597-601. PubMed ID: 20848202
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Liver transplantation meets gastrointestinal cancer.
    Loosen SH; Leyh C; Neumann UP; Bock H; Weigel C; Luedde T; Roderburg C
    Z Gastroenterol; 2024 Jan; 62(1):62-72. PubMed ID: 38195110
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term outcome of liver transplantation for combined hepatocellular carcinoma and cholangiocarcinoma.
    Park YH; Hwang S; Ahn CS; Kim KH; Moon DB; Ha TY; Song GW; Jung DH; Park GC; Namgoong JM; Park CS; Park HW; Kang SH; Jung BH; Lee SG
    Transplant Proc; 2013 Oct; 45(8):3038-40. PubMed ID: 24157031
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Can machine learning radiomics provide pre-operative differentiation of combined hepatocellular cholangiocarcinoma from hepatocellular carcinoma and cholangiocarcinoma to inform optimal treatment planning?
    Liu X; Khalvati F; Namdar K; Fischer S; Lewis S; Taouli B; Haider MA; Jhaveri KS
    Eur Radiol; 2021 Jan; 31(1):244-255. PubMed ID: 32749585
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Liver transplantation for malignancies.
    Eghtesad B; Aucejo F
    J Gastrointest Cancer; 2014 Sep; 45(3):353-62. PubMed ID: 24604263
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Liver transplantation in the MELD era--analysis of the OPTN/UNOS registry.
    Taniguchi M
    Clin Transpl; 2012; ():41-65. PubMed ID: 23721009
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of primary hepatic malignancy in liver transplant candidates: prospective comparison of CT, MR imaging, US, and PET.
    Teefey SA; Hildeboldt CC; Dehdashti F; Siegel BA; Peters MG; Heiken JP; Brown JJ; McFarland EG; Middleton WD; Balfe DM; Ritter JH
    Radiology; 2003 Feb; 226(2):533-42. PubMed ID: 12563151
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Distinguishing intrahepatic cholangiocarcinoma from hepatocellular carcinoma in patients with and without risks: the evaluation of the LR-M criteria of contrast-enhanced ultrasound liver imaging reporting and data system version 2017.
    Li F; Li Q; Liu Y; Han J; Zheng W; Huang Y; Zheng X; Cao L; Zhou JH
    Eur Radiol; 2020 Jan; 30(1):461-470. PubMed ID: 31297632
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list.
    Vitale A; Volk ML; De Feo TM; Burra P; Frigo AC; Ramirez Morales R; De Carlis L; Belli L; Colledan M; Fagiuoli S; Rossi G; Andorno E; Baccarani U; Regalia E; Vivarelli M; Donataccio M; Cillo U;
    J Hepatol; 2014 Feb; 60(2):290-7. PubMed ID: 24161408
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of neoadjuvant chemoradiation, followed by liver transplantation, for perihilar cholangiocarcinoma at 12 US centers.
    Darwish Murad S; Kim WR; Harnois DM; Douglas DD; Burton J; Kulik LM; Botha JF; Mezrich JD; Chapman WC; Schwartz JJ; Hong JC; Emond JC; Jeon H; Rosen CB; Gores GJ; Heimbach JK
    Gastroenterology; 2012 Jul; 143(1):88-98.e3; quiz e14. PubMed ID: 22504095
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Liver transplantation for primary and metastatic liver cancers.
    Hoti E; Adam R
    Transpl Int; 2008 Dec; 21(12):1107-17. PubMed ID: 18713148
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Distinguishing intrahepatic mass-forming biliary carcinomas from hepatocellular carcinoma by computed tomography and magnetic resonance imaging using the Bayesian method: a bi-center study.
    Ichikawa S; Isoda H; Shimizu T; Tamada D; Taura K; Togashi K; Onishi H; Motosugi U
    Eur Radiol; 2020 Nov; 30(11):5992-6002. PubMed ID: 32500195
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor diagnosis in the adult liver transplant candidate.
    Mahfouz A; Vogl T; Hamm B
    Eur Radiol; 1999; 9(5):841-52. PubMed ID: 10369978
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Updates and Expert Opinions on Liver Transplantation for Gastrointestinal Malignancies.
    Shannon AH; Ruff SM; Schenk AD; Washburn K; Pawlik TM
    Medicina (Kaunas); 2023 Jul; 59(7):. PubMed ID: 37512101
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Value of fusing PET plus CT images in hepatocellular carcinoma and combined hepatocellular and cholangiocarcinoma patients with extrahepatic metastases: preliminary findings.
    Nagaoka S; Itano S; Ishibashi M; Torimura T; Baba K; Akiyoshi J; Kurogi J; Matsugaki S; Inoue K; Tajiri N; Takada A; Ando E; Kuromatsu R; Kaida H; Kurogi M; Koga H; Kumashiro R; Hayabuchi N; Kojiro M; Sata M
    Liver Int; 2006 Sep; 26(7):781-8. PubMed ID: 16911459
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumors with intrahepatic bile duct differentiation in cirrhosis: implications on outcomes after liver transplantation.
    Facciuto ME; Singh MK; Lubezky N; Selim MA; Robinson D; Kim-Schluger L; Florman S; Ward SC; Thung SN; Fiel M; Schiano TD
    Transplantation; 2015 Jan; 99(1):151-7. PubMed ID: 25029385
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Liver transplantation for combined hepatocellular-cholangiocarcinoma: Outcomes and prognostic factors for mortality. A multicenter analysis.
    Jaradat D; Bagias G; Lorf T; Tokat Y; Obed A; Oezcelik A
    Clin Transplant; 2021 Feb; 35(2):e14094. PubMed ID: 32970878
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intraductal malignant tumors in the liver mimicking cholangiocarcinoma: Imaging features for differential diagnosis.
    Kim AY; Jeong WK
    Clin Mol Hepatol; 2016 Mar; 22(1):192-7. PubMed ID: 27044773
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.